Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina, Chapel Hill, NC 27599, USA.
Gastroenterol Res Pract. 2010;2010. doi: 10.1155/2010/453563. Epub 2010 Jul 28.
Emerging evidence suggests a strong interaction between the gut microbiota and health and disease. The interactions of the gut microbiota and the liver have only recently been investigated in detail. Receiving approximately 70% of its blood supply from the intestinal venous outflow, the liver represents the first line of defense against gut-derived antigens and is equipped with a broad array of immune cells (i.e., macrophages, lymphocytes, natural killer cells, and dendritic cells) to accomplish this function. In the setting of tissue injury, whereby the liver is otherwise damaged (e.g., viral infection, toxin exposure, ischemic tissue damage, etc.), these same immune cell populations and their interactions with the infiltrating gut bacteria likely contribute to and promote these pathologies. The following paper will highlight recent studies investigating the relationship between the gut microbiota, liver biology, and pathobiology. Defining these connections will likely provide new targets for therapy or prevention of a wide variety of acute and chronic liver pathologies.
新出现的证据表明,肠道微生物群与健康和疾病之间存在很强的相互作用。肠道微生物群与肝脏的相互作用最近才被详细研究。肝脏从肠道静脉流出中获得约 70%的血液供应,是抵御肠道来源抗原的第一道防线,并且配备了广泛的免疫细胞(即巨噬细胞、淋巴细胞、自然杀伤细胞和树突状细胞)来完成这一功能。在组织损伤的情况下,肝脏受到损害(例如,病毒感染、毒素暴露、缺血性组织损伤等),这些相同的免疫细胞群体及其与浸润肠道细菌的相互作用可能导致并促进这些病理。以下论文将重点介绍最近研究肠道微生物群、肝脏生物学和病理生物学之间关系的研究。定义这些联系可能为治疗或预防各种急性和慢性肝病提供新的靶点。